Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.
NCT02223299 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2020-02-21
Summary
\*\*This study never received IRB approval and no participants were ever enrolled\*\* The purpose of this study is to determine if adding over the counter nutritional supplements will have a benefit to participants currently taking prescribed antidepressants who have not experienced complete remission of their depression symptoms.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
L-tyrosine
6g/d daily for 30 days
- DIETARY_SUPPLEMENT
-
L-Tryptophan
2g/d daily for 30 days
- DRUG
-
deplin
15mg daily for 30 days
- OTHER
-
Placebo A
a sugar-pill that looks like a real medication
- OTHER
-
Placebo B
a sugar-pill that looks like a real medication
Sponsors & Collaborators
-
John D. Dingell VA Medical Center
lead FED
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Post-Traumatic Brain Injury (TBI) Depression
NCT00233103 ·Status: COMPLETED ·Phase: PHASE2
-
TC-5214 as add-on the Treatment of Major Depressive Disorder
NCT00692445 ·Status: COMPLETED ·Phase: PHASE2
-
Deprexil in Subjects With Signs and Symptoms of Depression
NCT01043367 ·Status: COMPLETED ·Phase: PHASE3
-
Probiotic Supplementation in Severe Depression
NCT02957591 ·Status: COMPLETED ·Phase: NA
-
Can Additional Drug Therapy Accelerate Response Time to Antidepressants
NCT00221494 ·Status: WITHDRAWN ·Phase: PHASE4
-
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
NCT01001559 ·Status: COMPLETED
-
Mood, Serotonin and Social Interaction
NCT02051530 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
SSRIs vs. TCAs for Depression in ALS Patients
NCT02851914 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline
NCT01250873 ·Status: COMPLETED ·Phase: PHASE1
-
Serotonin Function During Depression
NCT00033787 ·Status: COMPLETED
-
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
NCT00125957 ·Status: COMPLETED ·Phase: PHASE3
-
Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
NCT00285727 ·Status: COMPLETED ·Phase: NA
-
Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
NCT00158990 ·Status: COMPLETED ·Phase: PHASE3
-
Citalopram for Sx/Util in Acute Coronary Syndrome Patients
NCT01667744 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder
NCT05148169 ·Status: UNKNOWN ·Phase: PHASE4
-
Antidepressant Discontinuation in Treatment Resistant Depression
NCT03786614 ·Status: UNKNOWN ·Phase: NA
-
Thyroid Medication and Antidepressants for Treating Major Depression
NCT00208702 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
NCT04532749 ·Status: TERMINATED ·Phase: PHASE3
-
The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
NCT00581009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression
NCT01671124 ·Status: UNKNOWN
-
Platelet Function in Patients Treated With SSRI and Non-SSRI Antidepressants
NCT00009568 ·Status: COMPLETED
-
Sub-chronic Effects of 5-hydroxytryptophan on Mood and Emotional Processing in Healthy Volunteers
NCT01514409 ·Status: COMPLETED ·Phase: NA
-
Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder
NCT05271084 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
NCT00953745 ·Status: COMPLETED ·Phase: NA
-
Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression
NCT01099592 ·Status: TERMINATED ·Phase: PHASE4